Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Alto Neuroscience, Inc. ANRO

Set alert

Price alert · ANRO

All alert types
22.19 USD -0.41 -1.81%

At close · Nov 2

22.19 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
22.13 × 200
Ask
22.29 × 100
21.50 Day range 23.18
10.20 52-week range 37.48
YTD
+24.66%
1 year
+56.38%
Open
22.80
Prev close
22.60
Mkt cap
870.78M
Vol
473.27K
Avg vol
563.52K
EPS
-2.31
P/E
0.00
Div yield
0.00%
More statistics
Low
21.50
High
23.18
Forward P/E
-7.78
Beta
1.16
Short ratio
8.92
Inst. own
87.06%
Dividend
0.00
Ex-div date
Earnings
Nov 11, 2026
50-d avg
31.01
200-d avg
23.57
1y target
38.38

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for ANRO has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

13.38 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 2

Valuation

P/E -8.1×
FY 2021: -57.5×FY 2022: -19.2×FY 2023: -15.3×FY 2024: -1.7×FY 2025: -8.1×
FY 2021 5y median -15.3× FY 2025
P/S 0.0×
FY 2021: 2521×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2021 5y median 0.0× FY 2025
P/B 3.4×
FY 2021: -42.4×FY 2022: -13.8×FY 2023: -7.8×FY 2024: 0.7×FY 2025: 3.4×
FY 2021 5y median -7.8× FY 2025
P/FCF -9.9×
FY 2021: -53.2×FY 2022: -25.1×FY 2023: -16.4×FY 2024: -2.1×FY 2025: -9.9×
FY 2021 5y median -16.4× FY 2025
EV/EBITDA -5.7×
FY 2021: -59.9×FY 2022: -20.6×FY 2023: -14.0×FY 2024: 0.8×FY 2025: -5.7×
FY 2021 5y median -14.0× FY 2025
EV/Sales 0.0×
FY 2021: 2580×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2021 5y median 0.0× FY 2025
FCF Yield -10.1%
FY 2021: -1.9%FY 2022: -4.0%FY 2023: -6.1%FY 2024: -47.6%FY 2025: -10.1%
FY 2021 5y median -6.1% FY 2025

Profitability

Gross Margin 0.0%
FY 2021: 31.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2021: -5741.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2021: -4374.8%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
ROE -41.8%
FY 2021: 73.6%FY 2022: 72.2%FY 2023: 50.7%FY 2024: -40.6%FY 2025: -41.8%
FY 2021 5y median 50.7% FY 2025
ROIC -38.2%
FY 2021: -44.7%FY 2022: -64.0%FY 2023: -46.6%FY 2024: -40.7%FY 2025: -38.2%
FY 2021 5y median -44.7% FY 2025
ROA -34.2%
FY 2021: -31.9%FY 2022: -54.5%FY 2023: -41.9%FY 2024: -34.6%FY 2025: -34.2%
FY 2021 5y median -34.6% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2021: 0.0%FY 2022: -100.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 FY 2025
Operating Income 3.3%
FY 2021: 0.0%FY 2022: -142.1%FY 2023: -29.5%FY 2024: -81.5%FY 2025: 3.3%
FY 2021 FY 2025
EPS (diluted) 12.4%
FY 2021: 0.0%FY 2022: -200.0%FY 2023: -25.0%FY 2024: -85.2%FY 2025: 12.4%
FY 2021 FY 2025
Free Cash Flow -4.6%
FY 2021: 0.0%FY 2022: -112.5%FY 2023: -60.6%FY 2024: -45.9%FY 2025: -4.6%
FY 2021 FY 2025

Financial Health

Current Ratio 15.7×
FY 2021: 15.3×FY 2022: 8.9×FY 2023: 15.2×FY 2024: 16.9×FY 2025: 15.7×
FY 2021 5y median 15.3× FY 2025
Quick Ratio 15.7×
FY 2021: 15.3×FY 2022: 8.9×FY 2023: 15.2×FY 2024: 16.9×FY 2025: 15.7×
FY 2021 5y median 15.3× FY 2025
Debt / Equity 0.0×
FY 2021: -3.1×FY 2022: -2.1×FY 2023: -0.1×FY 2024: 0.1×FY 2025: 0.0×
FY 2021 5y median -0.1× FY 2025
Net Debt / EBITDA 2.9×
FY 2021: -1.4×FY 2022: -1.2×FY 2023: 2.1×FY 2024: 2.4×FY 2025: 2.9×
FY 2021 5y median 2.1× FY 2025
Interest Coverage -26.9×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: -27.6×FY 2024: 49.9×FY 2025: -26.9×
FY 2021 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31